Medifast, Inc. (MED)

Market Cap	223.99M
Revenue (ttm)	897.81M
Net Income (ttm)	67.76M
Shares Out	10.94M
EPS (ttm)	6.20
PE Ratio	3.30
Forward PE	37.90
Dividend	$1.65 (8.06%)
Ex-Dividend Date	Sep 18, 2023

Volume	350,267
Open	21.02
Previous Close	21.03
Day's Range	20.06 - 21.02
52-Week Range	18.81 - 109.52
Beta	1.18
Analysts	Sell
Price Target	49.75 (+142.92%)
Earnings Date	Aug 5, 2024

About MED

Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is he...

• Industry: Personal Services
• Sector: Consumer Discretionary
• Founded: 1980
• Employees: 634
• Stock Exchange: NYSE
• Ticker Symbol: MED

Financial Performance

In 2023, Medifast's revenue was $1.07 billion, a decrease of -32.94% compared to the previous year's $1.60 billion. Earnings were $99.42 million, a decrease of -30.75%.

Analyst Forecast

According to 2 analysts, the average rating for MED stock is "Sell." The 12-month stock price forecast is $49.75, which is an increase of 142.92% from the latest price.

Price Target

$49.75

(142.92% upside)

Analyst Consensus: Sell